Nano-crystals a comprehensive review on formulation and application perspectives

Rakesh Mishra, Sagar Dhadwad, Akash Aher, Prajakta Dhokale
{"title":"Nano-crystals a comprehensive review on formulation and application perspectives","authors":"Rakesh Mishra, Sagar Dhadwad, Akash Aher, Prajakta Dhokale","doi":"10.55522/jmpas.v12i3.4798","DOIUrl":null,"url":null,"abstract":"A majority of recently invented medications have been discovered to be poorly water-soluble and cause delays in the formulation and development of dosage forms. Solubility has been a major problem for BCS classes II and IV. As a result, nanotechnology may be useful in resolving the solubility problem. This review will cover Nanocrystals, as well as the numerous methodologies employed in their formulation and their application. Nanocrystals are nanometre-sized drug particles of a poorly water-soluble compound. They are distinct from polymeric nanoparticles in that they are entirely made up of the drug. Nanocrystals can be implemented to increase the rate of dissolution and saturation solubility of active pharmaceutical ingredients. Milling, high-pressure homogenization, precipitation, and combination methods such as Nanoedge andSmartCrystal, are among the approaches available for its formulation. The transition of nanocrystals into final formulations, as well as future nanocrystal trends, are also discussed.","PeriodicalId":16445,"journal":{"name":"Journal of Medical pharmaceutical and allied sciences","volume":"27 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical pharmaceutical and allied sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55522/jmpas.v12i3.4798","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A majority of recently invented medications have been discovered to be poorly water-soluble and cause delays in the formulation and development of dosage forms. Solubility has been a major problem for BCS classes II and IV. As a result, nanotechnology may be useful in resolving the solubility problem. This review will cover Nanocrystals, as well as the numerous methodologies employed in their formulation and their application. Nanocrystals are nanometre-sized drug particles of a poorly water-soluble compound. They are distinct from polymeric nanoparticles in that they are entirely made up of the drug. Nanocrystals can be implemented to increase the rate of dissolution and saturation solubility of active pharmaceutical ingredients. Milling, high-pressure homogenization, precipitation, and combination methods such as Nanoedge andSmartCrystal, are among the approaches available for its formulation. The transition of nanocrystals into final formulations, as well as future nanocrystal trends, are also discussed.
综述了纳米晶体的制备及其应用前景
大多数最近发明的药物已被发现水溶性很差,导致剂型的配方和开发延迟。溶解度一直是BCS II类和IV类的主要问题。因此,纳米技术可能有助于解决溶解度问题。这篇综述将涵盖纳米晶体,以及在它们的配方和应用中使用的许多方法。纳米晶体是一种水溶性差的化合物的纳米大小的药物颗粒。它们不同于聚合纳米粒子,因为它们完全由药物组成。纳米晶体可以提高活性药物成分的溶解速率和饱和溶解度。铣削、高压均质、沉淀和组合方法(如Nanoedge和smartcrystal)都是可用于其配方的方法。本文还讨论了纳米晶体向最终配方的转变,以及未来纳米晶体的发展趋势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信